C REACTIVE PROTEIN	CRP
HYDROXY 3 METHYLGLUTARYL COENZYME A	HMG-CoA
HIGH SENSITIVE C REACTIVE PROTEIN	hs-CRP
HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2	HER2
CARDIOVASCULAR DISEASE	CVD
OSTEOPROTEGERIN	OPG
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB	RANK
RANK LIGAND	RANKL
HOMOCYSTEINE	HCY
HCY LEVELS	HHCY
OSTEOPOROSIS	OP
CV DISEASES	CVD
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPAB	RANK
CHRONIC KIDNEY DISEASE	CKD
VITAMIN K ANTAGONISTS	VKA	VKAs
ORAL ANTICOAGULANTS	OA
OSTEOCALCIN	OC
BONE MORPHOGENETIC PROTEIN 2	BMP-2
QUALITY OF LIFE	QOL
PSEUDOTUMOUR	PT
INFLAMMATORY BOWEL DISEASE	IBD
THROMBIN GENERATION	TG
CALIBRATED AUTOMATED THROMBOGRAPHY	CAT
PEDIATRIC ULCERATIVE COLITIS DISEASE ACTIVITY INDEX	PUCAI
ENDOGENOUS THROMBIN POTENTIAL	ETP
PHOSPHOLIPIDS	PL
PLATELET RICH PLASMA	PRP
VON WILLEBRAND DISEASE	VWD
COAGULASE NEGATIVE STAPHYLOCOCCI	CoNS
METHICILLIN RESISTANT STAPHYLOCOCCI	MRSA
METHICILLIN SUSCEPTIBLE STAPHYLOCOCCCI	MSSA
MOLAR INCISOR HYPOMINERALIZATION	MIH
POSITIVE PREDICTIVE VALUE	PPV
NEGATIVE PREDICTIVE VALUE	NPV
DIRECT VISUAL	DV
INDIRECT VISUAL	IDV
TEMPOROMANDIBULAR DISORDERS	TMD
HYPOHIDROTIC ECTODERMAL DYSPLASIA	HED
JUVENILE RECURRENT PAROTITIS	JRP
LACRIMO AURICULODENTO DIGITAL	LADD
LACRIMO AURICULO DENTO DIGITAL	LADD
FIBROBLAST GROWTH FACTOR RECEPTORS 2	FGFR2
LONG ACTING INJECTIONS	LAIs
FIRST GENERATION ANTIPSYCHOTIC	FGA
FIRST GENERATION ANTIPSYCHOTIC LONG ACTING INJECTIONS	FGA-LAIs
RANDOMISED CONTROLLED TRIALS	RCTs
SECOND GENERATION ANTIPSYCHOTICS	SGAs
LONG ACTING INJECTION	LAI
LONG ACTING ANTIPSYCHOTICS	LAIs
COMMUNITY TREATMENT ORDER	CTO
SECOND GENERATION ANTIPSYCHOTIC	SGA
NEWBORN SCREENING	NBS
CYSTIC FIBROSIS	CF
CFTR RELATED METABOLIC SYNDROME	CRMS
EUROPEAN HEALTHY CITIES NETWORK	EHCN
CITY HEALTH PROFILES	CHPs
HEALTH IMPACT ASSESSMENT	HIA
EUROPEAN UNION	EU
CITY HEALTH DEVELOPMENT PLANNING	CHDP
HEALTHY URBAN PLANNING	HUP
WHO EUROPEAN HEALTHY CITIES NETWORK	WHO-EHCN
HUMAN PAPILLOMAVIRUSES	HPVs
CERVICAL INTRAEPITHELIAL NEOPLASM	CIN
INVASIVE CANCER OF THE CERVIX	ICC
IMMUNE MEDIATED INFLAMMATORY DISEASES	IMID
TUMOR NECROSIS FACTOR	TNF
MAMMALIAN TARGET OF RAPAMYCIN	mTOR
HUMAN PAPILLOMAVIRUS	HPV
LYNDON B. JOHNSON	LBJ
INTRODUCTORY PHARMACY PRACTICE EXPERIENCE	IPPE
ADVANCED PHARMACY PRACTICE EXPERIENCE	APPE
ACUTE RESPIRATORY INFECTION	ARI
PERCUTANEOUS CORONARY INTERVENTIONS	PCI
OPPRESSION QUESTIONNAIRE	OQ
BODY MASS INDEX	BMI
PATIENT SAFETY INDICATORS	PSI
MINIMUM BASIC DATA SET	MBDS
ADVERSE EVENTS	AEs	AE
IDENTIFICATION OF ADVERSE	IDEA
CARDIOPULMONARY ARREST	CPA
INTENSIVE CARE UNITS	ICUs
SAFETY CLIMATE SURVEY	SCS
INTENSIVE CARE UNIT	ICU
NATIONAL COMPREHENSIVE CANCER NETWORK	NCCN
MELODIC INTONATION THERAPY	MIT
BOTULINUM TOXIN TYPE A	BoNTA	BoNT-A	BTXA
LATERAL CANTHAL LINES	LCLs
LATERAL CANTHAL AREAS	LCAs
HYALURONIC ACID	HA
FACIAL WRINKLE SCALE	FWS
ALOPECIA AREATA	AA
BOTULINUM TOXIN	BT
COMPLETE SECONDARY THERAPY FAILURE	CSTF
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE	SIADH
ARGININE VASOPRESSIN	AVP
Γ AMINOBUTYRIC ACID	GABA
METASTATIC BREAST CANCER	mBC
RANDOMISED CONTROLLED TRIAL	RCT
PROGRESSION FREE SURVIVAL	PFS
FUNCTIONAL ASSESSMENT OF CANCER THERAPY FOR BREAST	FACT-B
INCREMENTAL COST EFFECTIVENESS RATIOS	ICERs
EUROPEAN UNION POPULATION	EUP
CLINICALLY SIGNIFICANT	CS
CLINICALLY SIGNIFICANT SEVERE	CSS
IDIOPATHIC THROMBOCYTOPENIC PURPURA	ITP
INCREMENTAL COST EFFECTIVENESS RATIO	ICER
QUALITY ADJUSTED LIFE YEAR	QALY
IMMUNOHISTOCHEMISTRY	IHC
FLUORESCENCE IN SITU HYBRIDISATION	FISH
5 FLUOROURACIL	5-FU
EPIRUBICIN, OXALIPLATIN,	EOX
EPIRUBICIN, CISPLATIN, 5 FU	ECF
HCX OR TRASTUZUMAB, CISPLATIN, 5 FU	HCF
QUALITY ADJUSTED LIFE YEARS	QALYs
PATIENT ASSESSMENT OF CONSTIPATION QUALITY OF LIFE	PAC-QOL
PATIENT ASSESSMENT OF CONSTIPATION SYMPTOMS	PAC-SYM
EUROPEAN QUALITY OF LIFE 5 DIMENSIONS	EQ-5D
RELATIVE RISK	RR
CHRONIC LYMPHOCYTIC LEUKAEMIA	CLL
OVERALL SURVIVAL	OS
DOUBLE REFRACTORY	DR
BEST SUPPORTIVE CARE	BSC
PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE	PLDH
MIXED TREATMENT COMPARISON	MTC
SYSTOLIC BLOOD PRESSURE	SBP
PSORIATIC ARTHRITIS	PsA
PSORIATIC ARTHRITIS RESPONSE CRITERIA	PsARC
HEALTH ASSESSMENT QUESTIONNAIRE	HAQ
TUMOUR NECROSIS FACTOR	TNF
TOTAL VARIATION	TV
FILTERED BACKPROJECTION	FBP
COMPUTED TOMOGRAPHY	CT
FLUENCE FIELD MODULATED CT	FFMCT
INTENSITY MODULATED RADIATION THERAPY	IMRT
SIGNAL TO NOISE RATIO	SNR
REGIONS OF INTEREST	ROIs
NONPREWHITENING MATCHED FILTER WITH AN EYE	NPWE
PROPORTION CORRECT	PC
TWO ALTERNATIVE FORCED CHOICE	2-AFC
VOLUME RENDERING TECHNIQUES	VRT
DIFFERENTIAL BACKPROJECTION	DBP
BACKPROJECTION FILTRATION	BPF
CALCIUM SENSING RECEPTOR	CaSR	CASR
PROTEIN KINASE	PK
PEROXISOME PROLIFERATOR ACTIVATOR	PPAR
RELATED PEPTIDE	rP
PRIMARY HYPERPARATHYROIDISM	PHPT	P-HPT
MULTIPLE ENDOCRINE NEOPLASIA	MEN
HYPERPARATHYROIDISM JAW TUMOR	HPTJT
FAMILIAL ISOLATED HYPERPARATHYROIDISM	FIHP
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	FHH
NEONATAL SEVERE HYPERPARATHYROIDISM	NSHPT
MULTIPLE ENDOCRINE NEOPLASIA	MEN
BONE MINERAL DENSITY	BMD
ASYMPTOMATIC PHPT	aPHPT
EVIDENCE BASED PRACTICE FOR IMPROVING QUALITY	EPIQ
NEONATAL INTENSIVE CARE UNIT	NICU
PROVINCIAL HEALTH OFFICER	PHO
RESPONSIVE, INTERSECTORAL INTERDISCIPLINARY, CHILD COMMUNITY, HEALTH, EDUCATION AND RESEARCH	RICHER
INTER PROFESSIONAL CARE	IPC
PAEDIATRIC ASTHMA CLINIC	PAC
ADOLESCENTS WITH SPECIAL HEALTHCARE NEEDS	ASHCN
FETAL FIBRONECTIN	fFn
POSITIVE BEHAVIOUR SUPPORT	PBS
THROMBOCYTOPATHY	TCP
PARTIAL THROMBOPLASTIN TIME	PTT
MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION	MLPA
ELECTROMYOGRAPHY	EMG
VON WILLEBRAND JÜRGENS SYNDROME	VWJS
OCULOCUTANEOUS ALBINISM	OCA
HERMANSKY PUDLAK SYNDROME	HPS
BLEEDING DISORDERS	BD
IDIOPATHIC GENERALIZED EPILEPSY	IGE
INTERICTAL EPILEPTIFORM DISCHARGES	IED
AROUSAL DISORDERS	AD
NOCTURNAL FRONTAL LOBE EPILEPSY	NFLE
AGRYPNIA EXCITATA	AE
FATAL FAMILIAL INSOMNIA	FFI
DELIRIUM TREMENS	DT
MORVAN SYNDROME	MS
STEREO EEG	SEEG
IDIOPATHIC REM SLEEP BEHAVIOR DISORDER	iRBD
REM SLEEP BEHAVIOR DISORDER	RBD
RAPID EYE MOVEMENT	REM
NOT CLINICAL RBD	NC-RBD
ELECTROMYOGRAPHIC	EMG
REM SLEEP BEHAVIOUR DISORDER	RBD
STATUS DISSOCIATUS	SD
ADJUSTED ODDS RATIO	AOR
HYPOPLASTIC LEFT HEART SYNDROME	HLHS
ATTENTION DEFICIT HYPER ACTIVITY DISORDER	ADHD
DIAGNOSTISCH INTERVIEW VOOR ADHD	DIVA
ADULT SELF REPORT SCALE	ASRS
ATTENTION DEFICIT HYPERACTIVITY DISORDER	ADHD
FUNCTIONAL MAGNETIC RESONANCE IMAGING	fMRI
EVENT RELATED POTENTIALS	ERP
AUTISM SPECTRUM DISORDERS	ASD
AUTISM SPECTRUM DISORDER	ASD
BEHAVIOR RATING INVENTORY FOR EXECUTIVE FUNCTION	BRIEF
ONABOTULINUMTOXIN A	OnabotA
RHINOSINUSITIS	RS
ACUTE OTITIS MEDIA	AOM
CHRONIC RHINOSINUSITIS	CRS
PATIENT REPORTED OUTCOMES	PROs
HEALTH RELATED QUALITY OF LIFE	HRQL
VALVE ACADEMIC RESEARCH CONSORTIUM	VARC
PARAVALVULAR LEAK	PVL
TRANSCATHETER AORTIC VALVE IMPLANTATION	TAVI
AORTIC REGURGITATION	AR
PARAVALVULAR	PV
MITRAL REGURGITATION	MR
TRANSCATHETER AORTIC VALVE REPLACEMENT	TAVR
DIRECT FLOW MEDICAL	DFM
TRANSCATHETER HEART VALVE	THV
TRANSCATHETER HEART VALVES	THV
PITYRIASIS ALBA	PA
ATOPIC DERMATITIS	AD
INVESTIGATOR GLOBAL ASSESSMENT	IGA
VISUAL ANALOGUE SCALE	VAS
ANTIBODY DRUG CONJUGATES	ADCs
DYNAMIC CONTRAST ENHANCED	DCE
DIFFUSION WEIGHTED IMAGING	DWI
SEXUALLY TRANSMITTED DISEASES	STDs
JOURNAL OF DENTAL HYGIENE	JDH
EVIDENCE BASED DECISION MAKING	EBDM
INTERPROFESSIONAL COLLABORATION	IPC
PEGYLATED INTERFERON	PEG-IFN
CARDIAC TROPONINS	cTn
HIGH SENSITIVITY	hs
ACUTE MYOCARDIAL INFARCTION	AMI
INTERNATIONAL NORMALIZED RATIO	INR
POINT OF CARE	POC
ABERRANT CRYPT FOCI	ACF
STANDARDIZED INCIDENCE RATIO	SIR
EXCESS ABSOLUTE RISK	EAR
RENAL REPLACEMENT THERAPY	RRT
PER MILLION POPULATION	pmp
END STAGE RENAL DISEASE	ESRD
HEMODIALYSIS	HD
PERITONEAL DIALYSIS	PD
HEMODIAFILTRATION	HDF
AUTOMATED PERITONEAL DIALYSIS	APD
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS	CAPD
FRIENDLY SUMMARY OF THE BODY OF EVIDENCE USING EPISTEMONIKOS	FRISBEE
CHRONIC HEART FAILURE	CHF
CARBAPENEMASE PRODUCING ENTEROBACTERIA	CPE
RECURRENT APHTHOUS STOMATITIS	RAS
METHICILLIN RESISTANT S. AUREUS	MRSA
DISSEMINATED INTRAVASCULAR COAGULATION	DIC
ANTIBODIES	Abs
CORONARY ARTERY BYPASS GRAFT	CABG
PERCUTANEOUS CORONARY INTERVENTION	PCI
SURGICAL VENTRICULAR RECONSTRUCTION	SVR
ATRIAL FIBRILLATION	AF
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY	HAART
BURANA VIRUS	BURV
TAMDY VIRUS	TAMV
SYR DARYA VALLEY FEVER VIRUS	SDVFV
WAD MEDANI VIRUS	WMV
KEMEROVO	KEMV
END EXPIRATORY ESOPHAGEAL PRESSURE	EEEP
PLATEAU PRESSURE	Ptp
INTRA ABDOMINAL PRES	IAP
GLIAL FIBRILLARY ACIDIC PROTEIN	GFAP
METABOTROPIC GLUTAMATE RECEPTOR	mGluR
GASTRIC CANCER	GC
SERUM PEPSINOGENS	sPG
HELICOBACTER PYLORI	Hp
ALCOHOLIC LIVER DISEASE	ALD
THE PRODUCTIVE OPERATING THEATRE	TPOT
NATURAL ANTIBODIES	NAbs
LANDOMYCIN A	LA
REACTIVE OXYGEN SPECIES	ROS
NITRIC OXIDE	NO
BRONCHOALVEOLAR LAVAGE	BAL
OVALBUMIN	OVA
NEUROMUSCULAR DISEASES	NMD
LARYNGOTRACHEAL SEPARATION	LTS
TRACHEAL FLAP METHOD	TFM
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME	PRES
ACUTE LYMPHOCYTIC LEUKEMIA	ALL
ARTERIAL SPIN LABELING	ASL
EPSTEIN BARR VIRUS	EBV
EPSTEIN BARR	EB
EB VIRUS	EBV
PEDIATRIC INTENSIVE CARE UNIT	PICU
PEDIATRIC CLINICAL ILLNESS SCORE	PCIS
PENTRAXIN 3	PTX3
ENZYME LINKED IMMUNOSORBENT ASSAY	ELISA
BRAIN TYPE NATRIURETIC PEPTIDE	BNP
PLASMA CALCITONIN	PCT
PEDIATRIC CRITICAL ILLNESS SCORE	PCIS
OXYGENATION INDEX	OI
HEART RATE	HR
MEAN ARTERIAL BLOOD PRESSURE	MAP
MULTIPLE ORGAN DYSFUNCTION SYNDROME	MODS
REVERSE TRANSCRIPTION PCR	RT-PCR
COXSACKIEVIRUS A6	CA6
COXSACKIEVIRUS A16	CA16
HIGH SENSITIVITY C REACTIVE PROTEIN	hsCRP
PROLINE RICH TRANSMEMBRANE PROTEIN 2	PRRT2
PAROXYSMAL KINESIGENIC DYSKINESIA	PKD
HYDROXY ISOBUTYRYL COA HYDROLASE	HIBCH
ORGANIC CARBON	OC
ELEMENTAL CARBON	EC
SECONDARY ORGANIC CARBON	SOC
TOTAL NH3	TNH3
VOLATILE ORGANIC COMPOUNDS	VOCs
LIPOSOMAL PBS	L-PBS
